Spots Global Cancer Trial Database for carcinoma, non small cell lung
Every month we try and update this database with for carcinoma, non small cell lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer | NCT00798720 | Carcinoma, Non ... | vorinostat bortezomib | 18 Years - | University of Wisconsin, Madison | |
| THIO Sequenced With Cemiplimab in Advanced NSCLC | NCT05208944 | Carcinoma, Non-... | 6-Thio-2'-Deoxy... Cemiplimab | 18 Years - | Maia Biotechnology | |
| PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib | NCT00548093 | Carcinoma, Non ... | PF-00299804 PF-00299804 | 18 Years - 99 Years | Pfizer | |
| Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer | NCT01671332 | Carcinoma, Non ... | Docetaxel Suramin Docetaxel | 18 Years - | University of Wisconsin, Madison | |
| Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis | NCT00184964 | Carcinoma, Non ... | CT-scan, PET-sc... | 18 Years - | Radboud University Medical Center | |
| Computed Tomography (CT) Perfusion Imaging of Lung Cancer | NCT00905801 | Carcinoma, Non ... | CT Perfusion | 18 Years - | University of Pittsburgh | |
| Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer | NCT00954278 | Carcinoma, Non ... | sorafenib | 18 Years - | University of Wisconsin, Madison | |
| Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | NCT00191256 | Carcinoma, Non ... | Gemcitabine Carboplatin Paclitaxel | 18 Years - | Eli Lilly and Company | |
| Healthy Directions After Lung Surgery Pilot | NCT02135211 | Carcinoma, Non ... | Lifestyle couns... | 21 Years - | Dana-Farber Cancer Institute | |
| A Study Of PF-06263507 In Patients With Advanced Solid Tumors | NCT01891669 | Neoplasms Carcinoma, Non ... Breast Neoplasm... Ovarian Neoplas... | PF-06263507 PF-06263507 | 18 Years - | Pfizer | |
| Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer | NCT00934076 | Carcinoma, Non ... | Tarceva plus AT... | 19 Years - | University of Alabama at Birmingham | |
| Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer | NCT00553254 | Carcinoma, Non ... | PF-00299804 | 18 Years - | Pfizer | |
| Computed Tomography (CT) Perfusion Imaging of Lung Cancer | NCT00905801 | Carcinoma, Non ... | CT Perfusion | 18 Years - | University of Pittsburgh | |
| TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer | NCT01282151 | Carcinoma, Non ... | Taxotere Pemetrexed | 18 Years - | Chonnam National University Hospital | |
| Computed Tomography (CT) Perfusion Imaging of Lung Cancer | NCT00905801 | Carcinoma, Non ... | CT Perfusion | 18 Years - | University of Pittsburgh | |
| Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | NCT00191230 | Carcinoma, Non ... | gemcitabine carboplatin cisplatin | 18 Years - | Eli Lilly and Company | |
| THIO Sequenced With Cemiplimab in Advanced NSCLC | NCT05208944 | Carcinoma, Non-... | 6-Thio-2'-Deoxy... Cemiplimab | 18 Years - | Maia Biotechnology | |
| PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib | NCT00548093 | Carcinoma, Non ... | PF-00299804 PF-00299804 | 18 Years - 99 Years | Pfizer | |
| A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC) | NCT01469000 | Carcinoma, Non ... | Gefitinib Pemetrexed | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
